Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE OF COMMON STOCK (Details Narrative)

v3.22.0.1
NET LOSS PER SHARE OF COMMON STOCK (Details Narrative) - shares
3 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Share-based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 10,700,626 8,659,134
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 360,000 560,000